These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Tushuizen ME; Diamant M; Sturk A; Nieuwland R Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062 [TBL] [Abstract][Full Text] [Related]
4. The many faces of endothelial microparticles. Dignat-George F; Boulanger CM Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):27-33. PubMed ID: 21160065 [TBL] [Abstract][Full Text] [Related]
5. Microparticles, vascular function and hypertension. Boulanger CM Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):177-80. PubMed ID: 20051854 [TBL] [Abstract][Full Text] [Related]
6. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? Pericleous C; Giles I; Rahman A Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261 [TBL] [Abstract][Full Text] [Related]
7. [Circulating endothelial microparticles: a new marker of vascular injury]. Boulanger CM; Leroyer AS; Amabile N; Tedgui A Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117 [TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction: a potential tool in gender related cardiovascular disease. Patel PD; Arora RR Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):89-100. PubMed ID: 19124412 [TBL] [Abstract][Full Text] [Related]
9. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Berezin A; Zulli A; Kerrigan S; Petrovic D; Kruzliak P Clin Biochem; 2015 Jun; 48(9):562-8. PubMed ID: 25697107 [TBL] [Abstract][Full Text] [Related]
10. Endothelial function testing as a biomarker of vascular disease. Verma S; Buchanan MR; Anderson TJ Circulation; 2003 Oct; 108(17):2054-9. PubMed ID: 14581384 [No Abstract] [Full Text] [Related]
11. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689 [TBL] [Abstract][Full Text] [Related]
12. The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. Friedewald VE; Giles TD; Pool JL; Yancy CW; Roberts WC Am J Cardiol; 2008 Aug; 102(4):418-23. PubMed ID: 18678298 [No Abstract] [Full Text] [Related]
13. New markers of inflammation and endothelial cell activation: Part I. Szmitko PE; Wang CH; Weisel RD; de Almeida JR; Anderson TJ; Verma S Circulation; 2003 Oct; 108(16):1917-23. PubMed ID: 14568885 [No Abstract] [Full Text] [Related]
14. Cell-derived microparticles in haemostasis and vascular medicine. Burnier L; Fontana P; Kwak BR; Angelillo-Scherrer A Thromb Haemost; 2009 Mar; 101(3):439-51. PubMed ID: 19277403 [TBL] [Abstract][Full Text] [Related]